Pattern of RNA based blood biomarkers in squamous cell carcinoma cervix treated with definitive Radiotherapy: A pilot Study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2017 - 2020
Project Lead
Avinash H Udayashankara
Authors
Avinash H Udayashankara, Sweta Srivastava, Mazhar H Shariff
Project Status
completed
Project Type
Prospective Observational Study